Trial intelligence / Profile preview

HOME: Lipidem vs Lipofundin MCT in Home Parenteral Nutrition

NCT03282955Phase 4Completed

Sponsor
B. Braun
Start
Jan 2018
Primary completion
Jul 2022
Modality
Nanoparticles
Countries
5
01

Overview

A Phase 4 trial of Lipidem in intestinal failure (IF), sponsored by B. Braun. Started Jan 2018; status: completed.

02

Drugs

Lipidem
03

Conditions

intestinal failure (IF)

Beyond the preview

Go deeper on NCT03282955.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03282955.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call